| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
| mRNA |
Topotecan |
FIMM |
pan-cancer |
AAC |
-0.02 |
0.8 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.011 |
0.8 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |